Corporate
Description
  • Value proposition

    We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

    Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.

    For more information, visit ipsen.com.

    Pauta exclusiva para México:
    Clave de Autorización COFEPRIS: 243300201B1962
    CONSULTE A SU MÉDICO.

    Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, and Primary Care

  • Original language

    We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

    Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.

    For more information, visit ipsen.com.

    Pauta exclusiva para México:
    Clave de Autorización COFEPRIS: 243300201B1962
    CONSULTE A SU MÉDICO.

  • Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care

    Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care

  • https://www.ipsen.com/
Entity interactions BETA
Entity TypeTweets Articles
BFM Bourse BFM Bourse
Online Audio and Video Media
Other

17 Dec 2021


Collège des Directeurs du Développement Durable (C3D) Collège des Directeurs du Développement Durable (C3D)
greentech, cleantech, Civic and Social Organizations
Other

11 Jan 2022


Top Employers Institute Top Employers Institute
hrtech, Human Resources Services
Other

20 Jan 2022


Foundation For Rare Diseases Foundation For Rare Diseases
deeptech, Research Services
Other

31 May 2022

25 Jun 2024



IDA Ireland IDA Ireland
International Trade and Development
Other

16 Feb 2022


Radars
Loading...